CAS: 1621862-70-1; Cpi-1205

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-10457640-B2
      优先权日:2016-10-19
      标 题:Synthesis of inhibitors of EZH2
      发明人:VASWANI RISHI G; HEWITT MICHAEL CHARLES
      权利人:CONSTELLATION PHARMACEUTICALS INC
      摘要:Provided herein are synthetic methods for the preparation of EZH2 inhibitors.

      专利号:US-2019233375-A1
      优先权日:2016-10-19
      标题:Synthesis of inhibitors of ezh2

      专利号:US-2025236590-A1
      优先权日:2021-10-20
      标题 :A method for the preparation of indole-3-carboxylic acid derivatives
      发明人:DEB INDUBHUSAN
      权利人:DEB INDUBHUSAN
      摘要:The present invention provides a new synthetic method for the preparation of building block indole-3-carboxylic acid (ICA) derivatives used as a key starting material to produce several artificial drugs. An efficient, safe, operationally simple, cost-effective method for the preparation of several ICA derivatives has been introduced in a very simple way. Utilizing easily available starting material, reagent, and solvent several key starting materials of ICA derivatives have been synthesized rapidly indicates the novel method is functional group tolerable. The preparation process does not involve use of any reducing agents or transition metals in the economically viable and operationally simple condition in one pot. ICA derivatives have been generated from isatin derivative in one step and this methodology is important with a wide range of applications from the drug development and material synthesis CN point of view.

      专利号:EP-3529242-A1
      优先权日:2016-10-19
      标 题 :Synthesis of inhibitors of ezh2

      专利号:WO-2018075598-A1
      优先权日:2016-10-19
      标题 :Synthesis of inhibitors of ezh2
      湖北磊源生物技术有限公司
      ⚠️ 未注册 · 未认证企业
      ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
      数据来源于公开网络搜索,平台未作核实,请自行辨别。
      🏢敬请 企业认领
      🏬开设公司展台
      📢获取免费会员权益
      🎖️点亮专属注册企业标签
      📇展现公司完整信息 样本查看立即注册认领 →
      网址: http://www.leiyuanbio.com
      企业联系电话:18627229696👤
      📞湖北磊源生物技术有限公司 ⚠️参考联系方式
      联系人:邹兵
      电话:18627229696
      手机:18627229696

      邮箱:sales@leiyuanbio.com
      通信地址: 湖北省荆州市江陵临江产业园鹤鸣路11号
      邮编: 434100
      🆔 联系时候可告知是从"百琢研"平台获取的信息.
      ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

      地址:湖北省荆州市江陵临江产业园鹤鸣路11号
      ⚠️ 未注册 · 未认证企业
      注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
      ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
      第 1 / 1 页
      现货

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Vaswani RG, Gehling VS, Dakin LA, Cook A, Nasveschuk CG, Duplessis M, Iyer P, Balasubramanian S, Zhao F, Good AC, Campbell R, Lee C, Cantone N, Cummings RT, Normant E, Bellon SF, Albrecht BK, Harmange JP, Trojer P, Audia JE, Zhang Y, Justin N, Chen S, Wilson J, Gamblin S. Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1 -(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas. J Med Chem. 2016 Oct 14.

      合成参考文献


      参考文献:10.1016/j.ejmech.2024.116470
      摘要:Long L, Zhang H, Zhou Z, Duan L, Fan D, Wang R, Xu S, Qiao D, Zhu W. Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and structure-activity relationships. European Journal of Medicinal Chemistry. 2024 Jul;273():116470. doi: 10.1016/j.ejmech.2024.116470.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知